RACHEL CUNNINGHAM: Open Payments
NPI 1376018077 · ITHACA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 25 payments from 11 companies in 2025. Trend: 2023 $952 · 2024 $1,078 · 2025 $605
Food & beverage: $585Education: $20
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| ABBVIE INC. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| PFIZER INC. | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| QOL Medical, LLC | 1 | $30 |
| Sandoz Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: TREMFYA, ENTYVIO, XIFAXAN, RINVOQ, VOQUEZNA, DUPIXENT, XELJANZ, Sucraid.
Industry payments across NY — which companies pay providers there.
